- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT00677703
Txt Now 2 Decrease Pregnancies L8r: A Study to Evaluate the Effect of Daily Text Message Reminders on Pill Continuation
The Effect of Text Message Reminders on Contraceptive Continuation, a Randomized Controlled Trial
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
In 2000, there were 84 pregnancies for every 1,000 women aged 15 to 19 in the US (4). More than 90% of the resulting 900,000 teen pregnancies were unintended (6). Nationwide, teen pregnancy rates have dropped 28% since their peak in 1990 but dropped only 15% in Hispanic teens (4). New York state ranks 38th in the nation with 91 teen pregnancies per 1,000 teens. For Whites the teen pregnancy rate is only 52. Teen pregnancy rates are two to three times higher in Hispanics (130 pregnancies) and African Americans (167 pregnancies)(4). In New York City, the teen pregnancy rate is 99, even higher than the NY state and US rates (8).
Unintended pregnancy has long-term consequences that can disproportionately affect teens. Teen pregnancy negatively affects a teen's socioeconomic status. Pregnant teens are less likely to finish their education, more likely to be single parents and less likely to acquire work experience (9). Teen pregnancies are more likely to be medically complicated, with higher maternal and infant morbidity and mortality rates than in older pregnant women (10). Over one third of teen pregnancies end in abortion. Once a teen has one delivery, she is at increased risk to have another. Furthermore, a daughter of a teen pregnancy is more likely to have a teen pregnancy herself (11). Consistent contraceptive use is the only way to prevent pregnancy (and all of its consequences) in sexually-active teens. In a study of OC use in our population, 99% of the pregnancies that did occur were in women who had discontinued their OC during the study period (1).
The National Survey of Family Growth, a nationwide study examining contraceptive use in 2,271 teenagers, showed that 98% of sexually-active teenagers had used a contraceptive method at some time (12). Among teen contraceptors, 53% use oral contraceptives (OC) - the highest percentage among all age groups (12). The percentage of African American and Hispanic teens using contraception is lower than white teens (12). The World Health Organization estimates that half of patients take their medication improperly (13). One million of the United States' unintended pregnancies result from improper OC use, failure or discontinuation (14). Teens discontinue OCs because they experience side effects, misunderstand instructions for use and do not establish a pill-taking routine (3). In a study of OC use in inner city family planning clinics, we found discontinuation rates of 40% and 61% at three and six months, respectively (1). For the 595 teens in that study, discontinuation rates were 53% and 75% at three and six months, respectively. High discontinuation rates are also reported elsewhere (15-19). Improving OC continuation in the U.S. by just 10% can lead to a 7% reduction in unintended pregnancies and an annual savings of $280 million (1995 dollars) (14). Nationally, that could mean a reduction of unintended teen pregnancies by 63,000.
Wireless text messaging is a technology that was effective in improving medication adherence in clinical trials of vaccines and smoking cessation in Spain and South Africa (20,21). Text messaging has also been found to be more effective than telephone call-backs and scheduled clinic revisits in providing patients in London with lab results and decreasing the time for them to return to clinic for treatment (22). Cell phones have more recently become widespread in America and cell phone use continues to increase. A 2005 survey of wireless providers revealed that there were nearly 208 million wireless subscribers in the US, nearly 26 million more than in 2004 (23). Americans use cell phones for more than talking; they can use the text message function to share photos, to vote for reality television programming contestants, to receive daily jokes or to receive ring tones. Sixty-four percent of teens with cell phones use text messaging (24). Urban teen girls are more likely to use text messaging than boys or adults (24).
To assess cell phone use in our own population we carried out a survey of 2,521 racially-diverse reproductive-aged women, including 473 teens, attending family planning clinics in NYC. Cell phone usage was 77% among teens, and 81% of them read and send text messages (5). One-third of the participants in this feasibility survey worry about forgetting to take their medications and 30% would like to receive text message reminders for this (5). There are no studies of the effectiveness of text message reminders on contraceptive continuation rates.
Successful teen pregnancy prevention programs use varied, multifactorial approaches (2). We propose a study using an existing technology, text messaging, in an innovative way to improve OC continuation rates. Daily text messages will provide information regarding side effects, their management and instructions for troubleshooting common pill-taking mistakes. They may also help teens and young women establish a dosing routine.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
New York
-
Brooklyn, New York, États-Unis, 11201
- Planned Parenthood Boro Hall
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- aged <25 years requesting OC as their primary method of contraception
- currently sexually active or anticipating sexual activity within the next 30 days
- owns cell phone with text messaging capability
Exclusion Criteria:
- contraindications to combined hormonal contraception per clinic protocol (e.g., hypertension)
- previous participation in this study
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Répartition: Randomisé
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Aucune intervention: Standard Care
Participants will receive standard care without daily reminders.
|
|
Expérimental: Text Messages
Participants will receive a daily text message reminder for 6 months
|
Text message reminders to take oral contraception daily: Each text message will be a short educational message listing the benefits of contraceptive use and providing instructions for avoiding common medication errors.
Autres noms:
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
---|---|
contraceptive continuation
Délai: 6 months
|
6 months
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
---|---|
change in contraceptive knowledge scores
Délai: 6 months
|
6 months
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Paula M Castano, MD, MPH, Columbia University
Publications et liens utiles
Publications générales
- Castano PM, Martinez RA. Harnessing technology for adolescent health promotion. Adolesc Med State Art Rev. 2007 Aug;18(2):400-6, xiii.
- Castano PM, Westhoff C, Andres Martinez R, Lara M. The effect of daily text message reminders on adolescent oral contraceptive pill continuation. Journal of Adolescent Health 44(2): S17, 2009.
- Hall KS, Westhoff CL, Castano PM. The impact of an educational text message intervention on young urban women's knowledge of oral contraception. Contraception. 2013 Apr;87(4):449-54. doi: 10.1016/j.contraception.2012.09.004. Epub 2012 Oct 10.
- Castano PM, Bynum JY, Andres R, Lara M, Westhoff C. Effect of daily text messages on oral contraceptive continuation: a randomized controlled trial. Obstet Gynecol. 2012 Jan;119(1):14-20. doi: 10.1097/AOG.0b013e31823d4167.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- AAAC1600
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Contraceptifs oraux
-
Wyeth is now a wholly owned subsidiary of PfizerComplété
-
University of Southern CaliforniaUnited States Department of DefenseComplété
-
Regenex Pharmaceutical, ChinaInconnueContraceptif oralChine
-
BayerComplétéContraceptif oralSuisse, Le Portugal, Chili, Italie, Corée, République de, Venezuela, Philippines, Colombie, Thaïlande, Argentine, Allemagne, Fédération Russe, Royaume-Uni, République tchèque
-
BayerComplétéContraceptif oralAllemagne
-
Teva Branded Pharmaceutical Products R&D, Inc.ComplétéContraceptif oral | HémostaseAllemagne, Israël, Italie, Espagne
-
Teva Women's HealthComplétéContraceptif oral | HémostaseÉtats-Unis, Italie
-
Teva Branded Pharmaceutical Products R&D, Inc.ComplétéContraceptif oral | Développement folliculaire | Follicule ovarien | Nombre de follicules | Taille du folliculeÉtats-Unis
-
Tibotec Pharmaceuticals, IrelandComplétéVIH | Contraceptif oral | Sida
Essais cliniques sur Daily Text Messages
-
Fundació d'investigació Sanitària de les Illes...Inscription sur invitationÉtat prédiabétiqueEspagne
-
Taipei Medical UniversityComplété
-
Birmingham Community Healthcare NHSNSA, LLCComplété
-
Galderma R&DComplétéIrritation de la peauÉtats-Unis
-
Boston UniversityNational Cancer Institute (NCI); Brown University; National Institutes of Health... et autres collaborateursComplété
-
Hacettepe UniversityComplétéAcidémie organique | Orientation cognitiveTurquie
-
Yale UniversityComplétéCancer du sein | Adhésion, Médicaments | Effet secondaireÉtats-Unis
-
Ankara City Hospital BilkentComplété
-
Bausch & Lomb IncorporatedComplété
-
Sunnybrook Health Sciences CentreCanadian Institutes of Health Research (CIHR); Ontario Neurotrauma FoundationComplétéChutes accidentelles | Équilibre musculo-squelettiqueCanada